Pharmacokinetics of Ampreloxetine, a Norepinephrine Reuptake Inhibitor, in Healthy Subjects and Adults with Attention-Deficit/Hyperactive Disorder or Fibromyalgia Pain - Kanodia, Jitendra; Lo, Arthur; Baldwin, R. Michael; Graham, Richard A.; Bourdet, David L. (Clinical pharmacokinetics, 2021)
Keywords: Adult; Attention Deficit Disorder with Hyperactivity - drug therapy; Attention Deficit Disorder with Hyperactivity - metabolism; Attention deficit hyperactivity disorder; Case-Control Studies; Catecholamines; Cytochrome; Drug dosages; Female; Fibromyalgia; Fibromyalgia - drug therapy; Fibromyalgia - metabolism; Humans; Hyperactivity; Internal Medicine; Male; Medicine; Medicine & Public Health; Metabolism; Norepinephrine; Original; Original Research Article; Orthostatic hypotension; Pain - drug therapy; Pain - metabolism; Pharmacokinetics; Pharmacology/Toxicology; Pharmacotherapy; Phenyl Ethers - administration & dosage; Phenyl Ethers - pharmacokinetics; Piperidines - administration & dosage; Piperidines - pharmacokinetics; Plasma; Population; Serotonin